Trial NCT02451111

View at ClinicalTrials.gov 
Org. Study IDs: SAKK 35/14
Secondary IDs: 2015-001487-19 SNCTP000001327

Last trial update was posted on 2024-03-13

MeSH Interventions

Ibrutinib Rituximab

MeSH Conditions

Lymphoma Lymphoma, Follicular

Other Conditions

Follicular Lymphoma

Stopping Reasons

The premature termination is based on the decision by the SAKK board on November 14, 2020 due to the lack of further financial support for the follow up period.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID